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National Trends in American Heart Association Revised Life's Simple 7 Metrics 
Associated With Risk of Mortality Among US Adults 
Abstract 
Importance: The American Heart Association (AHA) introduced the Life's Simple 7 (LS7) metrics to 
assess and promote cardiovascular health. However, several shortcomings of these metrics have been 
identified. Therefore, a revised set of LS7 metrics was developed. Objectives: To evaluate national trends 
in the metrics addressed by the revised LS7 and the individual and combined associations of the revised 
LS7 metrics with all-cause and cause-specific mortality and to compare these measures with the AHA 
recommended LS7 metrics. Design, Setting, and Participants: This national cross-sectional study used 
data from the National Health and Nutrition Examination Survey from 1988 to 2016. The revised LS7 
metrics included a combination of the body mass index and waist to hip ratio, Healthy Eating Index-2010, 
and a lower blood pressure threshold of greater than or equal to 130/80 mm Hg in addition to physical 
activity, smoking, total cholesterol, and fasting blood glucose. Data for this study were analyzed from 
June 1, 2017, to December 31, 2017. Main Outcomes and Measures: The primary outcome was all-cause 
mortality. The secondary outcome was cancer and cardiovascular disease (CVD) mortality. Results: Data 
were available for 13 606 adults in 1988 to 1994 (7329 [53%] female; mean [SD] age, 47 [17.7] years), 
6360 in 1999 to 2004 (3442 [54%] female; mean [SD] age, 47 [18.6] years), 10 618 in 2005 to 2010 (5428 
[51%] female; mean [SD] age, 47 [17.5] years), and 10 773 in 2011 to 2016 (5474 [50%] female; mean [SD] 
age, 48 [17.4] years). Compared with a revised LS7 score of 0 to 1, the adjusted hazard ratios for a revised 
LS7 score of 5 to 7 were 0.46 (95% CI, 0.35-0.61) for all-cause mortality, 0.42 (95% CI, 0.25-0.68) for 
cancer mortality, and 0.37 (95% CI, 0.24-0.55) for CVD mortality, respectively. The adjusted hazard ratios 
for participants who met 6 or more AHA recommended ideal LS7 metrics were 0.49 (95% CI, 0.33-0.74) 
for all-cause mortality, 0.60 (95% CI, 0.29-1.25) for cancer mortality, and 0.24 (95% CI, 0.13-0.47) for CVD 
mortality. Participants with a body mass index of 29.9 or less but without central obesity were 
independently associated with lower risk of all-cause and CVD mortality. Blood pressure was associated 
with 36.7% or more of the observed population-attributable fraction of mortality. Conclusions and 
Relevance: The individual revised LS7 metrics with modified criteria regarding weight, blood pressure, and 
diet provide more information about factors associated with cancer mortality than the original AHA LS7 
metrics. 
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National Trends in American Heart Association Revised Life's
Simple 7Metrics AssociatedWith Risk ofMortality Among US Adults
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Abstract
IMPORTANCE The American Heart Association (AHA) introduced the Life’s Simple 7 (LS7) metrics
to assess and promote cardiovascular health. However, several shortcomings of these metrics have
been identified. Therefore, a revised set of LS7metrics was developed.
OBJECTIVES To evaluate national trends in themetrics addressed by the revised LS7 and the
individual and combined associations of the revised LS7metrics with all-cause and cause-specific
mortality and to compare thesemeasures with the AHA recommended LS7metrics.
DESIGN, SETTING, AND PARTICIPANTS This national cross-sectional study used data from the
National Health and Nutrition Examination Survey from 1988 to 2016. The revised LS7metrics
included a combination of the bodymass index andwaist to hip ratio, Healthy Eating Index–2010, and
a lower blood pressure threshold of greater than or equal to 130/80mmHg in addition to physical
activity, smoking, total cholesterol, and fasting blood glucose. Data for this study were analyzed from
June 1, 2017, to December 31, 2017.
MAINOUTCOMES ANDMEASURES The primary outcomewas all-causemortality. The secondary
outcomewas cancer and cardiovascular disease (CVD) mortality.
RESULTS Data were available for 13 606 adults in 1988 to 1994 (7329 [53%] female; mean [SD] age,
47 [17.7] years), 6360 in 1999 to 2004 (3442 [54%] female; mean [SD] age, 47 [18.6] years), 10 618
in 2005 to 2010 (5428 [51%] female; mean [SD] age, 47 [17.5] years), and 10 773 in 2011 to 2016
(5474 [50%] female; mean [SD] age, 48 [17.4] years). Compared with a revised LS7 score of 0 to 1,
the adjusted hazard ratios for a revised LS7 score of 5 to 7 were 0.46 (95%CI, 0.35-0.61) for all-cause
mortality, 0.42 (95% CI, 0.25-0.68) for cancer mortality, and 0.37 (95% CI, 0.24-0.55) for CVD
mortality, respectively. The adjusted hazard ratios for participants whomet 6 or more AHA
recommended ideal LS7metrics were 0.49 (95%CI, 0.33-0.74) for all-causemortality, 0.60 (95%CI,
0.29-1.25) for cancer mortality, and 0.24 (95% CI, 0.13-0.47) for CVDmortality. Participants with a
body mass index of 29.9 or less but without central obesity were independently associated with
lower risk of all-cause and CVDmortality. Blood pressure was associated with 36.7% or more of the
observed population-attributable fraction of mortality.
CONCLUSIONS ANDRELEVANCE The individual revised LS7metrics withmodified criteria
regarding weight, blood pressure, and diet providemore information about factors associated with
cancer mortality than the original AHA LS7metrics.
JAMA Network Open. 2019;2(10):e1913131. doi:10.1001/jamanetworkopen.2019.13131
Key Points
Question Are the revised Life’s Simple
7 (LS7) metrics associated with reduced
risk of all-cause, cancer, and
cardiovascular disease mortality
compared with the original American
Heart Association LS7metrics?
Findings This cross-sectional study
found that, compared with the original
metrics, the revised LS7 metrics were
associated with reduced cancer
mortality. For participants with body
mass index less than or equal to 29.9 but
without central obesity, the revised
metrics were independently associated
with decreased risk of all-cause and
cardiovascular disease mortality, with
blood pressure having the greatest
association with all mortality outcomes.
Meaning These findings indicate that
modified criteria regarding weight,
blood pressure, and diet in the revised
LS7 provide additional information
about factors associated with cancer
mortality.
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Introduction
The American Heart Association (AHA) proposed the Life’s Simple 7 (LS7) set of risk factors used to
indicate cardiovascular health.1 The LS7 comprises 7 ideal metrics, including 3 ideal health factors:
untreated systolic blood pressure (BP) less than 120 and diastolic BP less than 80mmHg, untreated
total cholesterol level less than 200mg/dL (to convert to millimoles per liter, multiply by 0.0259),
and untreated fasting blood glucose concentration less than 100mg/dL (to convert to millimoles per
liter, multiply by 0.0555). The LS7 also includes 4 ideal health behaviors: not smoking, maintaining a
body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) less
than 25, achievement of a goal physical activity level, and a diet meeting 4 to 5 target components
(recommended consumption levels of fruits and vegetables, fish, fiber-rich whole grains, sodium,
and sugar-sweetened beverages).1 In previous studies, adherence to the ideal LS7metrics was found
to be associated with decreased risks of cardiovascular disease (CVD),2 all-cause mortality,3
and cancer.4
However, further consideration suggests that a reconstruction of the LS7metrics should include
additional factors. For example, although the AHA-proposed LS7metrics include a BMI of less than
25 (a commonly used surrogate for normal weight),1 this measure is prone to misclassification,
especially in older populations.5,6 Central obesity, which is defined by the waist to hip ratio (WHR), is
amore sensitivemarker of body fat distribution that is associatedwith highermortality independent
of BMI.2 Furthermore, the 2015 to 2020Dietary Guidelines for Americans,7 which provide updated
evidence relevant to reducing the cardiovascular risk and additional recommendations for adopting a
healthy diet and lifestyle, recommend an integrated dietary pattern (Healthy Eating Index–2010).
Moreover, the new 2017 American College of Cardiology/American Heart Association guideline has
defined a new threshold for hypertension as a BP greater than or equal to 130/80 mmHg.8
Accordingly, we includedmodified weight, diet, and BP criteria in a revised set of LS7metrics with an
intention tomore efficiently assess cardiovascular health in populations.
We used nationally representative data from the US National Health and Nutrition Examination
Surveys (NHANES) from 1988 to 2016 to estimate national trends in the revised LS7metrics among
US adults aged 20 years and older.We also evaluated the individual and combined associations of the
revised LS7metrics on all-cause and cause-specific (eg, cancer and CVD)mortality and estimated the
population-attributable fractions (PAF) associated with adherence to each ideal revised LS7metric
and the combination thereof. The comparison with the AHA-recommended LS7 metrics was also
investigated.
Methods
Study Population
The NHANES is an ongoing, multistage, cross-sectional survey. Two data sets were used: NHANES III,
conducted from 1988 to 1994,8 and the continuous NHANES survey, with data collected from 1999
to 2016. The National Center for Health Statistics Research Ethics Review Board reviewed and
approved NHANES, and informed consent was obtained for all participants. This survey uses a
complex, stratified, multistage probability sampling design to deliver nationally representative data
on the health and nutritional status of the noninstitutionalized civilian population across the United
States. Specifically, the NHANES obtains abundant information about a range of health topics
through in-home interviews that address demographic, socioeconomic, dietary, and health-related
questions, followed by blood sampling at a mobile examination center. TheMedical School of Ningbo
University Review Board determined that the current study was exempt from review and patient
informed consent given the use of publicly available data. This study followed the Strengthening the
Reporting of Observational Studies in Epidemiology (STROBE) guideline for cross-sectional studies.
Our study is based on an analysis of data from the survey cycles corresponding to NHANES III
(1988-1994), 1999 to 2004, 2005 to 2010, and 2011 to 2016. Participants with a BMI less than 18.5 or
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a history of heart attack, congestive heart failure, stroke, skin cancer, and other cancers were
excluded because these factors are associated with a higher risk of mortality.9,10 Participants who
were pregnant or who were younger than 20 years were also excluded.
Definitions of the Revised LS7Metrics
Smoking Status
Current smokers were defined as thosewho answered yes to the following questions: “Do you smoke
cigarettes now?” and “Have you smoked at least 100 cigarettes in your lifetime?” Former smokers
included those who responded no to the first question but yes to the second. Never smokers were
those who responded no to both questions. The status of never smokers, former smokers, and
current smokers was defined as ideal, intermediate, and poor, respectively (Table 1).
Physical Activity
Prior to 1999, the NHANES III (1988-1994) assessed physical activity as themonthly frequency of
participation in the following types of leisure-time physical activity: walking, jogging, biking,
swimming, calisthenics, gardening, weight lifting, aerobics, dancing, and up to 4 additional activities.
However, the NHANES III did not collect data about activity duration. Responses were standardized
as times per week using the conversion factors 4.3 weeks per month and 30.4 days per month and
rounded to the nearest whole number. Each activity was then assigned a metabolic equivalent score
using a standardized coding scheme. Physical activity was calculated as the sum of the intensity
rating multiplied by the times (of each activity) per week. For the NHANES III (1988-1994), ideal
physical activity (physically active) was defined using the following cutoffs: a metabolic equivalent
score of 3.0 to 5.9 and participation 5 or more times per week, or a metabolic equivalent score of 6.0
or greater and participation 3 or more times per week (Table 1).11,12
After 1999, participants were categorized into ideal, intermediate, or poor leisure-time physical
activity levels based onwhether theymet the following recommendations for weekly activity: ideal,
75 minutes or more of vigorous activity or 150 minutes or more of moderate activity or 150 minutes
or more of combined moderate and vigorous physical activity; intermediate, more than 0 minutes
of physical activity but less than recommendations; and poor, 0minutes of physical activity (Table 1).
Diet
TheNHANES 1988 to 2016 estimated theHealthy Eating Index–2010 from 2 nonconsecutive 24-hour
recall periods.13 The total healthy diet score ranged from0 to 100, with greater scores indicating
superior diet quality. This measure was grouped into tertiles: ideal, greater than 69.3; intermediate,
56.9 to 69.3; and poor, less than 56.9 (Table 1).
BMI andWHR
We used a sex-stratified composite classification of the BMI andWHR to account for sex-stratified
differences within the same cohort.14 The detailed classifications are shown in eTable 1 in the
Supplement. A BMI-WHR level of 3 or greater (normal weight with central obesity) was defined as
poor; all other levels were defined as ideal.14 The NHANES 1999 to 2016 did not measure hip
circumference, and therefore theWHR is not available for the NHANES 1999 to 2004, 2005 to 2010,
and 2011 to 2016. Different combinations of theWHR and BMI were only available for NHANES III
(1988-1994) (Table 1).
Hypertension
The new 2017 American College of Cardiology/American Heart Association guideline updated the
threshold for hypertension to a BP of 130/80mmHg or greater.8 An untreated BP less than 120/80
mmHgwas defined as ideal (Table 1).
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Table 1. Definitions of Ideal, Intermediate, and Poor LS7Metrics for Adults
Goal/Metric
AHA Definitions
of LS7 Metricsa
Definitions for Revised LS7 Metrics
NHANES III, 1988-1994 NHANES 1999-2004 NHANES 2005-2010 NHANES 2011-2016
Smoking Status
Ideal Never or quit
>12 mo ago
Survey did not ask the time since
quitting smoking; we included the
participants who self-reported never
smoking in the ideal category for
consistent estimates across the
surveys
Survey asked the time since
quitting smoking; to be
consistent with NHANES III
estimate, we included the
participants who self-reported
never smoking in the ideal
category
Survey asked the time since
quitting smoking; to be
consistent with NHANES III
estimate, we included the
participants who self-reported
never smoking in the ideal
category
Survey asked the time since
quitting smoking; to be
consistent with NHANES III
estimate, we included the
participants who self-reported
never smoking in the ideal
category
Intermediate Former or quit
≤12 mo
Included all former smokers Included all former smokers Included all former smokers Included all former smokers
Poor Current smoking Current smoking Current smoking Current smoking Current smoking
BMI-WHRb
1 BMI <25 BMI ≤24.9 and WHR <0.9 for men;
BMI ≤24.9 and WHR<0.8 for women
NA NA NA
2 BMI 25-29.9 BMI ≤24.9 and WHR <1 for men;
BMI ≤24.9 and WHR <0.92 for women
NA NA NA
3 BMI ≥30.0 BMI ≤24.9 and WHR >1 for men;
BMI ≤24.9 and WHR >0.92 for women
NA NA NA
4 BMI ≤29.9 and WHR<0.9 for men;
BMI ≤29.9 and WHR<0.8 for women
NA NA NA
5 BMI ≤29.9 and WHR <1 for men;
BMI ≤29.9 and WHR <0.92 for women
NA NA NA
6 BMI ≤29.9 and WHR >1 for men;
BMI ≤29.9 and WHR >0.92 for women
NA NA NA
7 BMI ≥30 and WHR <0.9 for men;
BMI ≥30 and WHR <0.8 for women
NA NA NA
8 BMI ≥30 and WHR <1 for men;
BMI ≥30 and WHR <0.92 for women
NA NA NA
9 BMI ≥30 and WHR >1 for men;
BMI ≥30 and WHR >0.92 for women
NA NA NA
Physical Activity
Ideal ≥150 min/wk
moderate or ≥75
min/wk vigorous
or ≥150 min/wk
moderate +
vigorous
NHANES III did not ask the duration of
physical activities; we defined
physically active as engaging in
physical activities with 3≤METS<6 and
≥5 times/wk or physical activities with
METS ≥6 and 3.0 times/wk. Physical
activities included walking, jogging or
running, bicycling, swimming, aerobics
or aerobic dancing, other dancing,
calisthenics, gardening or yard work,
and other sports
≥150 min/wk moderate or ≥75
min/wk vigorous or ≥150
min/wk moderate + vigorous;
physical activities included
walking, jogging or running,
bicycling, swimming, aerobics
or aerobic dancing, other
dancing, calisthenics,
gardening or yard work, and
other sports
≥150 min/wk moderate or ≥75
min/wk vigorous or ≥150
min/wk moderate + vigorous;
physical activities included
walking, jogging or running,
bicycling, swimming, aerobics
or aerobic dancing, other
dancing, calisthenics,
gardening or yard work, and
other sports
≥150 min/wk moderate or
≥75 min/wk vigorous or ≥150
min/wk moderate + vigorous;
physical activities included
walking, jogging or running,
bicycling, swimming, aerobics
or aerobic dancing, other
dancing, calisthenics,
gardening or yard work, and
other sports
Intermediate 1-149 min/wk
moderate or
1-74 min/wk
vigorous or
1-149 min/wk
moderate +
vigorous
The difference between physically
active and no physical activity was
taken as intermediate
1-149 min/wk moderate or
1-74 min/wk vigorous or
1-149 min/wk
moderate + vigorous
1-149 min/wk moderate or
1-74 min/wk vigorous or
1-149 min/wk
moderate + vigorous
1-149 min/wk moderate or
1-74 min/wk vigorous or
1-149 min/wk
moderate + vigorous
Poor None None None None None
Healthy Diet Scorec
Ideal 4-5
Componentsd
Healthy eating index score
≥69.3
Healthy eating index score
≥69.3
Healthy eating index score
≥69.3
Healthy eating index score
≥69.3
Intermediate 2-3
Componentsd
Healthy eating index score
56.9-69.2
Healthy eating index score
56.9-69.2
Healthy eating index score
56.9-69.2
Healthy eating index score
56.9-69.2
Poor 0-1
Componentsd
Healthy eating index score
<56.9
Healthy eating index score
<56.9
Healthy eating index score
<56.9
Healthy eating index score
<56.9
Total Cholesterol
Ideal <200 mg/dL <200 mg/dL <200 mg/dL <200 mg/dL <200 mg/dL
Intermediate 200-239 mg/dL
or treated to
goal
200-239 mg/dL
or treated to goal
200-239 mg/dL
or treated to goal
200-239 mg/dL
or treated to goal
200-239 mg/dL
or treated to goal
Poor ≥240 mg/dL ≥240 mg/dL ≥240 mg/dL ≥240 mg/dL ≥240 mg/dL
(continued)
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Cholesterol
An untreated total cholesterol level less than 200mg/dL was defined as ideal. This value was
identical to the AHA definition of ideal total cholesterol (Table 1).
Fasting PlasmaGlucose
Hemoglobin A1c values of less than 5.7% and less than 6.0% (to convert to proportion of total
hemoglobin, multiply by 0.01) were used as proxies for fasting glucose levels less than 100 and less
than 125 mg/dL, respectively. An untreated fasting blood glucose level of less than 100 mg/dL was
defined as ideal (Table 1).
Revised Combined LS7Metrics
Each revised LS7metric was coded as 2 if categorized as ideal, 1 if categorized as intermediate, and 0
if categorized as poor. Category 3 BMI-WHR (normal weight with central obesity) was defined as
poor. The points for all revised LS7metrics were then summed. Details of the cutoff values for each
revised LS7 metric are described in Table 1. Participants with all available revised LS7 metrics were
included in our study.
Assessment of Outcomes
The primary outcomewas all-cause mortality, and the secondary outcomes were cause-specific
(cancer and CVD) mortality. Participants in the NHANES III (1988-1994) were prospectively followed
from the date of enrollment until December 31, 2011.15 The National Center for Health Statistics
ascertainedmortality data fromNational Death Index death certificate records bymatching the
Table 1. Definitions of Ideal, Intermediate, and Poor LS7Metrics for Adults (continued)
Goal/Metric
AHA Definitions
of LS7 Metricsa
Definitions for Revised LS7 Metrics
NHANES III, 1988-1994 NHANES 1999-2004 NHANES 2005-2010 NHANES 2011-2016
Blood Pressure
Ideale SBP <120/DBP
<80 mm Hg
SBP <120/DBP
<80 mm Hg
SBP <120/DBP
<80 mm Hg
SBP <120/DBP
<80 mm Hg
SBP <120/DBP
<80mmHg
Intermediate SBP 120-139
or DBP 80-89
mm Hg or
treated to goal
SBP 120-129 or
DBP <80 mm Hg or
treated to goal
SBP 120-129 or
DBP <80 mm Hg or
treated to goal
SBP 120-129 or
DBP <80 mm Hg or
treated to goal
SBP 120-129 or
DBP <80 mm Hg or
treated to goal
Poor SBP ≥140 or
DBP ≥90 mm Hg
SBP ≥130 or
DBP ≥80 mm Hg
SBP ≥130 or
DBP ≥80 mm Hg
SBP ≥130 or
DBP ≥80 mm Hg
SBP ≥130 or
DBP ≥80 mm Hg
Fasting Plasma Glucose
Ideal <100 mg/dL <100 mg/dL; fasting glucose was
available for a subsample of NHANES
III participants (n = 6939)
<100 mg/dL; fasting glucose
was available for a subsample
of NHANES 1999-2004
participants (n = 5635)
<100 mg/dL; fasting glucose
was available for a subsample
of NHANES 2005-2010
participants (n = 4124)
<100 mg/dL; fasting glucose
was available for a subsample
of NHANES 2011-2014
participants (n = 6205)
Intermediate 100-125 mg/dL
or treated to
goal
100-125 mg/dL
or treated to goal
100-125 mg/dL
or treated to goal
100-125 mg/dL
or treated to goal
100-125 mg/dL
or treated to goal
Poor ≥126 mg/dL ≥126 mg/dL ≥126 mg/dL ≥126 mg/dL ≥126 mg/dL
Abbreviations: AHA, American Heart Association; BMI, bodymass index (calculated as
weight in kilograms divided by height in meters squared); DBP, diastolic blood pressure;
LS7, Life’s Simple 7; METS, metabolic equivalent score; NA, not available; NHANES,
National Health and Nutrition Examination Survey; SBP, systolic blood pressure; WHR,
waist to hip ratio.
SI conversion factors: To convert cholesterol to mmol/L, multiply by 0.0259; fasting
plasma glucose tommol/L, multiply by 0.0555.
a According to the AHA Strategic Impact Goal.1
b The classification of BMI combined withWHRwas based on the work of Sahakyan
et al.2 Category 3 BMI-WHR (normal weight with central obesity) was defined as poor.
c The healthy diet score was calculated based on the Healthy Eating Index–2010, a
measure of diet quality comprising 12 components. Nine components assess dietary
adequacy (intakes of total fruit, whole fruit, total vegetables, greens and beans, whole
grains, dairy, total protein foods, and seafood and plant proteins and fatty acid ratio),
with higher scores indicating higher consumption. Three components assess dietary
components that should be consumed in moderation (refined grains, sodium, and
empty calories), with higher scores indicating lower consumption.
d The first dietary metrics include fruits and vegetables (4.5 cups per day), fish (2 or
more 3.5-oz servings per week [preferably oily fish]), fiber-rich whole grains (3 or more
1-oz-equivalent servings per day), sodium (<1500mg per day), and sugar-sweetened
beverages (450 kcal [36 oz] per week). The secondary dietary metrics include nuts,
legumes, and seeds (4 servings per week); processed meats (none or2 servings
per week); and saturated fat (<7% of total energy intake).
e Untreated values, ie, no hypertension or high cholesterol levels.
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following data: Social Security number, name, date of birth, race/ethnicity, sex, state of birth, and
state of residence.16 The cause of death was classified as cancer (International Statistical
Classification of Diseases and Related Health Problems, Tenth Revision codes C00-C97) or CVD
(codes I00-I09, I11, I13, I20-I51).
Statistical Analysis
The baseline characteristics and revised LS7metrics are reported as weighted prevalence values and
confidence intervals. The person-years at risk were calculated from the baseline date to death, loss
to follow-up, or December 31, 2011, whichever came first. Trends were tested using a logistic
regression analysis that included a time variable equal to themedian of the cycles after adjusting for
age, sex, and race/ethnicity. Standard errors were estimated using Taylor series linearization.17
Participants in the NHANES III (1988-1994) were used for the association analysis. Cox
proportional hazards models were used to estimate the hazard ratios (HRs) and 95% confidence
intervals for single and combined revised LS7metrics after adjusting for age, sex, and race/ethnicity.
Additional adjustments included education (<12 or12 years), alcohol intake (0, <3, or3 drinks per
week; 1 drink was defined as 12 oz of beer, 4 oz of wine, or 1 oz of hard liquor), smoking, physical
activity, BMI, WHR, healthy diet score, total cholesterol, systolic BP, diastolic BP, and hemoglobin A1c
values. For additional adjustment, when we investigated the association between each revised LS7
metric and outcomes, the relevant variables were excluded. For example, when the association
between goal levels of untreated BP and outcomes was analyzed, systolic BP and diastolic BP were
not included in themodel.
Kaplan-Meier curves for all-cause and cause-specific mortality were generated using the
numbers of ideal revised LS7metrics and compared using the log-rank test. Proportional hazards
assumptions were evaluated by statistically testing the significance of time-dependent interaction
terms. Derivations from proportionality were not observed.
The PAF describes the attributable risk of mortality during follow-up due to nonadherence to
each revised LS7 metric and the revised combined metrics, with adjustment for age and sex.18 The
sensitivity analyses were stratified by sex (male or female), age (<60 or60 years), race/ethnicity
(non-Hispanic white, non-Hispanic black, Mexican American, or other), education (<12 or12 years),
and alcohol drinking (0, <3, or3 drinks per week). Interactionswere performed using the likelihood
ratio test with andwithout the cross-product interaction term. Another sensitivity analysis excluding
death during the first 5 years of follow-up was conducted to assess whether the results had been
influenced by reverse causation.
Sample weights were used for all analyses. Data were analyzed using SAS statistical software
version 9.4 (SAS Institute). Statistical significance was set at P < .05 using a 2-sided test.
Results
Data were available for 13 606 adults in NHANES III (1988-1994) (7329 [53%] female; mean [SD] age,
47 [17.7] years), 6360 in 1999 to 2004 (3442 [54%] female; mean [SD] age, 47 [18.6] years), 10 618
in 2005 to 2010 (5428 [51%] female; mean [SD] age, 47 [17.5] years), and 10 773 in 2011 to 2016
(5474 [50%] female; mean [SD] age, 48 [17.4] years). Participants in the NHANES III (1988-1994),
who were younger, female, more educated, more likely to be non-Hispanic white, and less likely to
consume alcohol than participants in other cycles, were more likely to have a greater number of ideal
revised LS7metrics (eTable 2 in the Supplement).
The characteristic distributions of the revised LS7metrics for all survey cycles are shown in
Table 2 and eTable 3 in the Supplement. Generally, less than 1% of the participants met all 6 to 7 ideal
revised LS7metrics, while approximately 21.8% to 30.7%met 2 or 3 of the ideal metrics (Table 2).
FromNHANES III (1988-1994) to 2011 to 2016, the weighted prevalence values of never smoking
increased, whereas those of the ideal physical activity level, healthy diet score, and untreated fasting
blood glucose level less than 100mg/dL decreased (Table 2).
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A total of 12 299 participants were included in the association analysis in NHANES III
(1988-1994). Of these participants, 4569 died during a median (range) follow-up of 19.16
(14.91-20.75) years (3015 all-cause deaths, 695 cancer deaths, and 859 CVD deaths). The Kaplan-
Meier survival curves for participants whomet 0 to 1, 2, 3, 4, or 5 to 7 ideal revised LS7metrics are
presented in Figure 1. Participants whomet 5 to 7 ideal revised LS7metrics had significantly lower
cumulative incidence rates of all-cause and cause-specific mortality compared with other groups
(P < .001 for all log-rank tests).
Table 3 and Figure 2 and eFigure 1 and eFigure 2 in the Supplement present the adjusted HRs
for all mortality outcomes according to the revised LS7metrics and AHA-recommended LS7metrics.3
Table 2.Weighted Prevalence ofMeeting Revised Life's Simple 7Metrics in Adults, NHANES III (1988-1994), 1999-2004, 2005-2010, and 2011-2016
Life's Simple 7
Metricsa
NHANES III, 1988-1994 NHANES 1999-2004 NHANES 2005-2010 NHANES 2011-2016
P for
Trendb
Respondents,
No.
Prevalence, %
(95% CI)
Respondents,
No.
Prevalence, %
(95% CI)
Respondents,
No.
Prevalence, %
(95% CI)
Respondents,
No.
Prevalence, %
(95% CI)
Smoking status
Never 6731 46.0 (44.3-47.7) 3460 53.1 (50.2-56.0) 6023 56.4 (54.4-58.3) 6679 61.0 (59.4-62.5) <.001
Former 3245 24.4 (23.1-25.7) 1680 25.0 (22.7-27.1) 2484 23.2 (21.9-24.4) 2287 23.0 (21.6-24.4) <.001
Current 3630 29.4 (27.7-31.1) 1220 21.9 (19.9-23.7) 2111 20.4 (18.8-21.9) 1807 16.0 (14.6-17.2) <.001
Physical activityc
Ideal 4008 31.0 (29.0-33.1) 992 16.7 (14.9-18.3) 459 5.00 (4.27-5.76) 2749 27.6 (26.2-29.0) <.001
Intermediate 6718 54.9 (53.2-56.5) 2506 47.0 (44.7-49.1) 1433 17.8 (15.3-20.1) 2842 29.8 (28.0-31.4) <.001
Poor 2880 14.0 (12.4-15.5) 2862 36.3 (33.7-38.9) 8726 77.2 (74.4-79.9) 5182 42.6 (40.2-44.8) <.001
BMI-WHRd
1 1839 17.2 (15.8-18.6) NA NA NA NA NA NA NA
2 2792 23.4 (22.2-24.7) NA NA NA NA NA NA NA
3 639 3.89 (3.35-4.43) NA NA NA NA NA NA NA
4 507 4.21 (3.59-4.83) NA NA NA NA NA NA NA
5 2542 18.9 (18.0-19.9) NA NA NA NA NA NA NA
6 1753 10.0 (9.27-10.8) NA NA NA NA NA NA NA
7 151 1.09 (0.83-1.35) NA NA NA NA NA NA NA
8 1501 9.83 (9.00-10.6) NA NA NA NA NA NA NA
9 1882 11.1 (10.4-11.9) NA NA NA NA NA NA NA
Healthy diet scoree
>69.3 4255 33.9 (32.2-35.6) 413 6.00 (4.89-6.97) 1248 11.9 (10.6-13.1) 1447 13.9 (12.8-15.1) <.001
56.9-69.3 4521 32.9 (31.3-34.5) 1070 14.8 (13.2-16.4) 2459 22.7 (21.4-23.9) 2414 22.9 (21.7-24.2) <.001
<56.9 4830 33.0 (31.0-35.0) 4877 79.2 (76.9-81.4) 6911 65.4 (63.2-67.5) 6912 63.0 (61.1-64.8) <.001
Total serum
cholesterol, mg/dL
<200
(Untreated)f
6853 51.4 (49.4-53.4) 2905 47.2 (45.2-49.1) 5292 50.1 (48.6-51.4) 5822 53.3 (51.5-55.1) <.001
200-239 or
treated to goal
4115 30.0 (28.6-31.5) 2275 34.6 (33.0-36.1) 3574 33.4 (32.1-34.6) 3476 32.5 (31.0-33.9) .68
≥240 2638 18.4 (17.1-19.7) 1180 18.2 (16.7-19.6) 1752 16.5 (15.5-17.5) 1475 14.2 (13.2-15.1) <.001
Blood pressure,
mm Hg
<120/80
(Untreated)f
5470 46.3 (44.3-48.2) 2300 42.5 (40.1-44.7) 4569 46.7 (45.0-48.3) 4758 47.2 (45.4-49.0) <.001
SBP 120-129 or
DBP <80 or
treated to goal
5120 33.7 (32.1-35.2) 2751 37.5 (35.7-39.3) 4306 37.3 (35.8-38.8) 4290 38.0 (36.2-39.6) .13
SBP ≥130 or
DBP ≥80
3016 19.9 (18.6-21.2) 1309 20.0 (18.4-21.6) 1743 16.0 (14.9-17.0) 1725 14.8 (13.5-16.1) <.001
Fasting blood
glucose, mg/dLg
<100 3451 72.8 (70.3-75.4) 1970 67.4 (65.4-69.4) 2661 57.3 (54.6-60.0) 1892 57.6 (54.9-60.3) <.001
100-125 1582 20.7 (18.8-22.7) 945 26.6 (24.6-28.5) 1951 36.2 (33.7-38.8) 1238 35.2 (32.7-37.6) <.001
≥126 551 6.33 (5.12-7.54) 283 6.00 (4.82-7.06) 488 6.50 (5.58-7.32) 327 7.20 (5.96-8.41) <.001
(continued)
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Bothmetrics exhibited inverse dose-response associations with all-cause or cause-specific mortality
(all P for trend < .001), except the association between the AHA-recommended LS7metrics and
cancer mortality (P for trend = .10) (Figure 2). Comparedwith participants whomet 0 to 1 of the ideal
revised LS7metrics, the adjusted HRs of participants whomet at least 5 metrics were 0.46 (95% CI,
0.35-0.61) for all-cause mortality, 0.42 (95% CI, 0.25-0.68) for cancer mortality, and 0.37 (95% CI,
0.24-0.55) for CVD mortality (Figure 2). The adjusted HRs of participants who met 6 or more
AHA-recommended ideal LS7metrics were 0.49 (95% CI, 0.33-0.74) for all-cause mortality, 0.60
(95% CI, 0.29-1.25) for cancer mortality, and 0.24 (95% CI, 0.13-0.47) for CVDmortality (Figure 2).
Of the individual revised LS7metrics, never smoking and an untreated BP less than 120/80mm
Hgwere associated with an independent lower risk for all outcomes. A BMI-WHR level of 5 (BMI
29.9 without central obesity) and untreated fasting blood glucose level less than 100mg/dL were
associated with an independent lower risk for all-cause and CVDmortality. A healthy diet score 69.3
or higher was associated with an independent lower risk for all-cause mortality. By contrast, an
untreated total cholesterol less than 200mg/dL was associated with an independent higher risk for
cancer mortality (Table 3).
We also performed stratified analyses by age, sex, race/ethnicity, education, and alcohol
consumption (eTables 4, 5, 6, 7, and 8 in the Supplement). Significant interaction between the
revised LS7 metrics and age was observed for cancer mortality (eFigure 3 in the Supplement; P for
interaction = .002), and significant interactions between the revised LS7metrics and educationwere
observed for all-cause and CVDmortality (P for interaction = .03 and P for interaction = .04,
respectively). The associations between the number of revised LS7 metrics and all outcomes were
more pronounced in younger participants (eTable 4 in the Supplement) and female participants
Table 2.Weighted Prevalence ofMeeting Revised Life's Simple 7Metrics in Adults, NHANES III (1988-1994), 1999-2004, 2005-2010, and 2011-2016 (continued)
Life's Simple 7
Metricsa
NHANES III, 1988-1994 NHANES 1999-2004 NHANES 2005-2010 NHANES 2011-2016
P for
Trendb
Respondents,
No.
Prevalence, %
(95% CI)
Respondents,
No.
Prevalence, %
(95% CI)
Respondents,
No.
Prevalence, %
(95% CI)
Respondents,
No.
Prevalence, %
(95% CI)
Ideal Life's Simple 7
metrics
0 562 3.08 (2.71-3.46) 324 3.60 (2.94-4.25) 626 4.40 (3.88-4.89) 199 1.70 (1.39-1.99) .07
1 1952 11.7 (10.6-12.7) 1266 16.9 (15.3-18.4) 2101 17.6 (16.3-18.7) 1322 11.8 (10.9-12.7) .03
2 3216 21.8 (20.4-23.1) 1964 30.7 (28.9-32.5) 3084 28.7 (27.6-29.7) 2865 25.4 (24.0-26.7) <.001
3 3389 25.0 (23.9-26.0) 1696 28.4 (26.6-30.1) 2895 29.4 (28.5-30.3) 3251 30.3 (28.9-31.6) <.001
4 2643 21.5 (20.5-22.6) 930 17.0 (15.5-18.4) 1700 17.4 (16.0-18.7) 2318 22.6 (28.9-31.6) .23
5 1349 12.0 (10.8-13.2) 176 3.30 (2.42-4.09) 208 2.50 (2.18-2.89) 732 7.20 (6.28-8.00) <.001
6 427 3.93 (3.23-4.62) 4 0.10 (0-0.19) 4 0 (0-0) 86 1.00 (0.79-1.28) <.001
7h 68 0.81 (0.53-1.09) NA NA NA NA NA NA NA
Abbreviations: BMI-WHR, bodymass index–waist hip ratio; DBP, diastolic blood pressure;
NA, not available; NHANES, National Health and Nutrition Examination Survey; SBP,
systolic blood pressure.
SI conversion factors: To convert total serum cholesterol to mmol/L, multiply by 0.0259;
fasting blood glucose tommol/L, mulitply by 0.0555.
a All nonpregnant participants older than 20 years with available revised Life's Simple 7
metrics were included.
b Trends across different surveys were analyzed by logistic regressionmodel adjusted for
age, sex, and race/ethnicity.
c For the NHANES III (1988-1994), ideal physical activity (physically active) was defined
using the following cutoffs: a metabolic equivalent score of 3 to 5.9 and participation 5
or more times per week, or a metabolic equivalent score of 6.0 or greater and
participation 3 or more times per week. None was defined as poor. For the NHANES
1999 to 2014, 75minutes or more of vigorous activity or 150minutes or more of
moderate activity or 150minutes ormore of combinedmoderate and vigorous physical
activity; intermediate, more than 0minutes of physical activity but less than
recommendations; and poor, 0minutes of physical activity. Physical activities included
walking, jogging or running, bicycling, swimming, aerobics or aerobic dancing, other
dancing, calisthenics, gardening or yard work, and other sports. The duration (minutes)
of physical activity changed largely at NHANES 2007 to 2008; trend analysis was
limited to NHANES 1999 to 2004 and NHANES 2005 to 2006.
d A BMI-WHR level of 3 or greater (normal weight with central obesity) was defined as
poor; all other levels were defined as ideal. The NHANES 1999 to 2016 did not measure
hip circumference, and therefore theWHR is not available for the NHANES 1999 to
2004, 2005 to 2010, and 2011 to 2016. Different combinations of the WHR and BMI
were only available for NHANES III (1988-1994).The classification of BMI combined
withWHRwas based on the work of Sahakyan et al.2
e The healthy diet score was calculated based on the healthy eating index advocated by
Dietary Guidelines for Americans7. The tertiles of the index were classified as ideal,
intermediate, and poor, respectively.
f Untreated value.
g Fasting glucose level was available for a subgroup of participants in NHANES III (1988-
1994) and NHANES 1999 to 2016. For trends, hemoglobin A1c values less than 5.7%
and 6.0%were used as proxies for fasting glucose levels less than 100mg/dL and 125
mg/dL, respectively.
h Values for WHRwere not available in NHANES 1999-2016.
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(eTable 5 in the Supplement). In another sensitivity test, 551 participants whose outcomes occurred
during the first 5 years of follow-up were excluded. The results in the remaining sample remained
similar to those observed in the full sample (data not shown).
Table 3 also presents the PAF for the individual revised ideal LS7metrics. The PAF analysis
indicated that 68.4% (95%CI, 63.1%-73.0%) of all-causemortality, 69.9% (95%CI, 31.2%-88.6%) of
cancer mortality, and 48.9% (95% CI, 28.7%-63.3%) of CVDmortality were associated with
nonadherence to the revised combined ideal LS7metrics (Figure 2), whereas 58.6% (95% CI, 33.2%-
76.1%) of all-cause mortality, 63.9% (95% CI, 28.0%-84.1%) of cancer mortality, and 44.3% (95%
Figure 1. All-Cause and Cause-Specific Mortality by Revised Life's Simple 7 (LS7)Metrics
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CI, 0%-76.0%) of CVDmortality were associated with nonadherence to the combined
AHA-recommended ideal LS7metrics (Figure 2). Blood pressure was themost significant individual
factor associated with all-cause mortality (PAF = 37.4%), cancer mortality (PAF = 36.7%), and CVD
mortality (PAF = 47.5%) (Table 3; eFigure 2 in the Supplement).
Figure2.AdjustedHazardRatios (HRs) andPopulation-AttributableFractions (PAFs) forAll-Causeand
Cause-SpecificMortalitybyRevisedLife's Simple7 (LS7)Metrics andAmericanHeartAssociation (AHA)LS7Metrics
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Because a small proportion of participantsmet none or
all of the LS7metrics, the revisedmetrics were
collapsed into 5 groups (0-1, 2, 3, 4, and 5-7). The PAF
for the revised LS7 metrics was adjusted for age and
sex. The PAF for the AHA-recommended LS7 metrics
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Discussion
Compared with the AHA-derived LS7, the revised LS7more clearly demonstrated an associated
reduction in the risk of cancer mortality. No significant dose-response association was observed
between the AHA-derived LS7metrics and cancer mortality, suggesting that the revisedmetrics are
more strongly associatedwith cancermortality than the AHA-derivedmetrics. Abdominal fat, such as
visceral adipose tissue and subcutaneous adipose tissue, was positively associatedwith all-cause and
cancer mortality rather than the CVD-related death in a prospective study.19 The diet components
recommended by AHA only focused on the promotion of cardiovascular health1; however, dietary
components in the Healthy Eating Index–2010 are more comprehensive.13 This may partly explain
why the combined revised LS7metrics are more strongly associated with cancer mortality.
A 68.4%, 69.9%, and 48.9% reduction in relative risk of all-cause, cancer, and CVDmortality
could be attributed to the ideal revised LS7 metrics, respectively. In the fully adjusted model,
participants with a BMI less than or equal to 29.9 but without central obesity had a decreased risk of
all-cause and CVDmortality. However, the AHA recommendation of a BMI less than 25 was not
associatedwith all-cause and CVDmortality in a previous study.3 Using the same data, central obesity
was found to correlate with a higher risk of CVDmortality in normal-weight participants compared
with those without central obesity (in BMI category).14 Similarly, a higher risk of mortality was
observed in patients with coronary artery disease and a largeWHR regardless of BMI.20 In our study,
we observed only aweak correlation of BMIwithWHR (correlation coefficient = 0.21), implying that
WHR and BMI provide different information.
Our findings further indicate the additional significance of theWHR beyond BMI. TheWHR is a
robust indicator of visceral fat, whereas the BMI reflects general adiposity. An increased WHR
parallels either a greater accumulation of the intra-abdominal fat mass or a greater decrease in the
gluteofemoral muscle mass,21 and intra-abdominal fat has been associated with CVDmortality.21
Overweight or obese participants may carry a greater proportion of subcutaneous fat in the hips and
legs, which is less associated with adverse outcomes compared with visceral fat.22 In contrast to
subcutaneous fat, visceral adipose tissue is associatedmore strongly with adverse metabolic risk
factors independent of BMI and waist circumference.23
A healthy diet score greater than or equal to 69.3 was independently associated with a reduced
risk of all-cause mortality in our study. However, the achievement of 2 or more dietary components
as defined by the AHA was not associated with all-cause mortality.12 Neither a healthy diet score of
69.3 or greater or 2 or more dietary components was found to be associated with CVD and cancer
mortality in a previous study.12 Most studies of the healthy diet score considered the separate
components of diets. However, as dietary components act collaboratively rather than individually,
the dietary pattern is more representative of the total quality than the individual intakes.
A total cholesterol level less than 200mg/dL was independently associated with a higher risk
of cancer mortality in our study. Consistent with our findings, other researchers reported an inverse
association between a low serum cholesterol level and increased cancer mortality.24,25 However,
unknown and unmeasured confounding factors affecting mortality and preexisting disease at
baseline might contribute to the observed increase in mortality.26 Still, the inverse association in our
study remained after further excluding participants whose outcomes occurred during the first 5 years
of follow-up.
In our study, BP was themost significant personal contributor, associated with 36.7% or more
of the PAF. An untreated BP less than 120/80mmHgwas associated with a reduced risk of all-cause
and CVDmortality under both the AHA-defined and revised LS7 metrics.3 Untreated BP less than
120/80mmHgwas associated with an HR for all-cause mortality of 0.73 (95% CI, 0.61-0.88) and HR
for CVDmortality of 0.56 (95%CI, 0.38-0.81) in our study, in contrast with 0.81 (95%CI 0.68–0.95)
for all-cause mortality and 0.64 (95% CI, 0.47-0.86) for CVDmortality in the study by Yang et al.3
Participants who were younger and female were more likely to meet a greater number of ideal
LS7 health metrics. The significant interactions observed between the ideal revised LS7 metrics and
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age on cancer mortality, and between the ideal revised LS7metrics and education on all-cause and
CVDmortality, suggest that the LS7 should be promotedmore strongly among high-risk groups.
When reestablishing our revised LS7metrics, we emphasized the conjunction of WHR and BMI,
an integrated dietary pattern (Healthy Eating Index–2010), and a new BP threshold for
hypertension.8 A strength of our study involves the use of standardized data from a large
representative sample of US adults. The NHANES applies stronger criteria to guaranteeminimal
nonsampling andmeasurement errors during survey planning, data collection, and processing. A
sensitivity analysis ensured the reliability of our findings. We carefully adjusted for potential
confounding factors and applied stringent exclusion criteria to reduce potential bias due to reverse
causation.
Limitations
This study has some limitations, so our findings should be interpreted cautiously. The comparison is
not direct, because few participants met all of the 6 to 7 revised LS7metrics in our study, so 7 groups
were collapsed into 5 groups (0-1, 2, 3, 4, and 5-7); however, 6 groups (0-1, 2, 3, 4, 5, and 6-7) were
classified for the AHA-recommended version.3 Second, the physical activity levels, smoking history,
and dietary records were self-reported in the NHANES surveys, whichmay have introduced recall
bias. Third, the revised LS7metrics were only available at baseline, and long-term changes (eg,
trajectories) in LS7metrics could not be captured. Misclassification error of underlying and
contributing causes of death and residual confounding and competing risks for cause-specific
mortalities should also be noted. In addition, because genetic data were not available, the potential
impact of genetic backgrounds in participants of different races/ethnicities on the association
between revised LS7 metrics and risks of mortality outcomes were not investigated. Furthermore,
the potential misclassification of the scoring approach in our study could not be avoided.
Conclusions
Our study indicated that few US adults met 6 to 7 ideal revised LS7metrics. For participants with BMI
less than or equal to 29.9 but without central obesity, the revisedmetrics were independently
associated with decreased risk of all-cause and cardiovascular disease mortality. The individual
revised LS7metrics with modified criteria regarding weight, BP, and diet providemore information
about factors associated with cancer mortality than the original AHA-derived LS7metrics.
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